SLDB Stock Summary and Trading Ideas (Solid Biosciences | NASDAQ:SLDB)

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

What symbol and exchange does Solid Biosciences shares trade?

Solid Biosciences trades on the NASDAQ stock market under the symbol SLDB.

What is Solid Biosciences stock price doing today?

As of July 29, 2026, SLDB stock price climbed to $8.04 with 877,967 million shares trading.

What is Solid Biosciences's Beta?

SLDB has a beta of 0.99, meaning it tends to be less sensitive to market movements. SLDB has a correlation of 0.03 to the broad based SPY ETF.

How much is Solid Biosciences worth?

SLDB has a market cap of $791.07 million. This is considered a Small Cap stock.

What is the highest and lowest price Solid Biosciences traded in the last 3 year period?

In the last 3 years, SLDB traded as high as $15.05 and as low as $1.81.

What are the top ETFs holding Solid Biosciences?

The top ETF exchange traded funds that SLDB belongs to (by Net Assets): VTI, XBI, IWM, VXF, IBB.

Is Solid Biosciences (SLDB) a good investment?

SLDB has underperformed the market in the last year with a price return of +14.5% while the SPY ETF gained +15.7%. However, in the short term, SLDB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.9% vs +2.8% return in SPY. But in the last 2 weeks, SLDB shares have been beat by the market, returning -16.5% compared to an SPY return of -3.0%.

What are the support and resistance levels for Solid Biosciences (SLDB)?

SLDB support price is $7.64 and resistance is $8.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SLDB shares will trade within this expected range on the day.